Drug Type Small molecule drug |
Synonyms DRF 11605, DRL 11605, DRL-11605 |
Target |
Mechanism PPARα agonists(Peroxisome proliferator-activated receptor α agonists), PPARγ agonists(Peroxisome proliferator-activated receptor γ agonists), PPARδ agonists(Peroxisome proliferator-activated receptor delta agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Obesity | Phase 1 | CA | - | |
Obesity | Phase 1 | - | - | |
Diabetes Mellitus, Type 2 | Preclinical | IN | - | |
Lipid Metabolism Disorders | Preclinical | IN | - |